CSF3 and progressive multifocal leukoencephalopathy: Granulocyte-colony stimulating factor G-CSF (known as filgrastim), which has been used to help restore immune system function after chemotherapy, has also previously been investigated to see if confers a benefit to patients with natalizumab-associated PML, as it may accelerate the development of IRIS to more effectively clear JCV (54).